NDATOPICALAEROSOL, FOAM
Approved
Jul 2015
Lifecycle
LOE Approaching
Competitive Pressure
15/100
Clinical Trials
14
Mechanism of Action
mechanism(s) by which azelaic acid interferes with the pathogenic events in rosacea are unknown.
Clinical Trials (5)
Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea
Started Dec 2017
5 enrolled
Rosacea, Papulopustular
A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea
Started Jul 2017
2,200 enrolled
Rosacea
Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study
Started May 2014
22 enrolled
Acne Rosacea
Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris
Started Feb 2014
222 enrolled
Acne Vulgaris
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
Started Sep 2012
961 enrolled
Papulopustular Rosacea
Loss of Exclusivity
LOE Date
Feb 28, 2029
36 months away
Patent Expiry
Feb 28, 2029
Company
Leo Pharma
Denmark - Ballerup